Dose-Escalation Study of Artesunate Patients With IPF
Abroad (travel likely)RecruitingPHASE1
Conditions
Idiopathic Pulmonary Fibrosis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Stanford University, Stanford, California, United States
Study leads
Joshua Mooney, MD
Principal Investigator
Stanford University